Total Payments
$1,700
2024 Payments
$1,475
Companies
17
Transactions
69
Medicare Patients
1,068
Medicare Billing
$76,789
Payment Breakdown by Category
Food & Beverage$1,600 (94.1%)
Education$99.99 (5.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,600 | 68 | 94.1% |
| Education | $99.99 | 1 | 5.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $289.51 | 10 | $0 (2024) |
| ABBVIE INC. | $245.34 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $189.43 | 8 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $165.78 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $153.17 | 9 | $0 (2024) |
| Galderma Laboratories, L.P. | $150.10 | 5 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $99.99 | 1 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $73.49 | 3 | $0 (2024) |
| Lilly USA, LLC | $61.55 | 3 | $0 (2024) |
| UCB, Inc. | $55.63 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,475 | 58 | GENZYME CORPORATION ($246.69) |
| 2023 | $147.79 | 6 | E.R. Squibb & Sons, L.L.C. ($32.30) |
| 2022 | $42.28 | 2 | GENZYME CORPORATION ($24.99) |
| 2019 | $11.88 | 1 | Galderma Laboratories, L.P. ($11.88) |
| 2018 | $10.77 | 1 | Sunovion Pharmaceuticals Inc. ($10.77) |
| 2017 | $12.84 | 1 | Novartis Pharmaceuticals Corporation ($12.84) |
All Payment Transactions
69 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Immunology | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.53 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $15.85 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/02/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.51 | General |
| Category: Immunology | ||||||
| 09/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $43.26 | General |
| Category: Immunology | ||||||
| 09/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.53 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $14.42 | General |
| Category: DERMATOLOGY | ||||||
| 09/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $30.91 | General |
| Category: Immunology | ||||||
| 08/29/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $32.77 | General |
| Category: Immunology | ||||||
| 08/27/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.08 | General |
| 08/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.16 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.80 | General |
| Category: Immunology | ||||||
| 08/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.39 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/08/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Dermatology | ||||||
| 08/06/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 07/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $41.79 | General |
| Category: Immunology | ||||||
| 07/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.97 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 146 | 206 | $33,838 | $9,521 |
| 2022 | 3 | 47 | 51 | $6,825 | $3,090 |
| 2021 | 9 | 448 | 930 | $75,921 | $33,231 |
| 2020 | 9 | 427 | 929 | $71,354 | $30,947 |
Total Patients
1,068
Total Services
2,116
Medicare Billing
$76,789
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 40 | $10,909 | $3,905 | 35.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 31 | 31 | $10,937 | $1,810 | 16.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 22 | $2,941 | $1,042 | 35.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $2,794 | $862.90 | 30.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 11 | 11 | $2,473 | $803.38 | 32.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 19 | 20 | $2,890 | $757.60 | 26.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 14 | 65 | $893.58 | $339.90 | 38.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 20 | $2,683 | $1,332 | 49.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $2,651 | $1,212 | 45.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 13 | 15 | $1,492 | $545.79 | 36.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 108 | 174 | $23,886 | $11,161 | 46.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 97 | 97 | $16,308 | $5,721 | 35.1% |
| 17000 | Destruction of skin growth | Office | 2021 | 71 | 103 | $10,310 | $4,423 | 42.9% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 13 | 26 | $6,528 | $3,201 | 49.0% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 36 | 40 | $6,337 | $2,975 | 46.9% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 57 | 415 | $4,153 | $2,031 | 48.9% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 18 | 19 | $3,285 | $1,742 | 53.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 33 | 41 | $3,474 | $1,577 | 45.4% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 15 | 15 | $1,641 | $399.68 | 24.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 72 | 111 | $18,093 | $7,980 | 44.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 112 | 112 | $18,104 | $6,576 | 36.3% |
| 17000 | Destruction of skin growth | Office | 2020 | 60 | 90 | $8,890 | $3,517 | 39.6% |
| 17004 | Destruction of 15 or more skin growths | Office | 2020 | 16 | 23 | $5,446 | $2,741 | 50.3% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 37 | 39 | $5,911 | $2,735 | 46.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 35 | 40 | $4,510 | $2,315 | 51.3% |
About Dr. Matthew Mittelbronn, MD
Dr. Matthew Mittelbronn, MD is a Dermatology healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801838537.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Mittelbronn, MD has received a total of $1,700 in payments from pharmaceutical and medical device companies, with $1,475 received in 2024. These payments were reported across 69 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,600).
As a Medicare-enrolled provider, Mittelbronn has provided services to 1,068 Medicare beneficiaries, totaling 2,116 services with total Medicare billing of $76,789. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Fort Worth, TX
- Active Since 06/10/2006
- Last Updated 11/17/2016
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1801838537
Products in Payments
- DUPIXENT (Biological) $542.67
- SKYRIZI (Biological) $182.72
- COSENTYX (Drug) $176.59
- Sotyktu (Drug) $165.78
- RINVOQ (Biological) $62.62
- TALTZ (Drug) $61.55
- Bimzelx (Biological) $55.63
- Zoryve (Drug) $48.75
- OPZELURA (Drug) $44.59
- AMELUZ (Drug) $43.29
- ADBRY (Biological) $37.36
- EUCRISA (Drug) $35.03
- SPEVIGO (Drug) $28.12
- AKLIEF (Drug) $18.61
- TREMFYA (Drug) $17.29
- XOLAIR (Biological) $12.84
- EPIDUO FORTE (Drug) $11.88
- APTIOM (Drug) $10.77
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Fort Worth
Dr. Patrick Keehan, D.o, D.O
Dermatology — Payments: $761,024
Dermatology $761,024
Dr. Ronald Plott, M.d, M.D
Dermatology — Payments: $467,637
Dermatology $467,637
William Cothern, Do, DO
Dermatology — Payments: $41,403
Dermatology $41,403
Stephen Weis, Do, DO
Dermatology — Payments: $32,162
Dermatology $32,162
Kathryn Durham, Md, MD
Dermatology — Payments: $28,437
Dermatology $28,437
Mrs. Betty Rajan, M.d, M.D
Dermatology — Payments: $25,857
Dermatology $25,857